Fernanda Tavares Da Silva

Statistics

Publications

Citations

871

H-Index

Active since

2011

Affiliations

GlaxoSmithKline (Belgium)(Current)

Sanofi (United States)

GlaxoSmithKline (United States)

Sanofi (France)

Universidade de São Paulo

Fernanda Tavares Da Silva is an author at GlaxoSmithKline (Belgium) specializing in immunization, adverse events following immunization, and veterinary medicine.

ORCID

Publications per year

2011–2023

Publications

Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data

Fernanda Tavares Da Silva, Bernard Gonik, Mark McMillan et al. · Vaccine · 2016 · 203 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

Paul Goepfert, Bo Fu, Anne-Laure Chabanon et al. · The Lancet Infectious Diseases · 2021 · 123 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial

Geert Leroux‐Roels, Arnaud Marchant, Jack Lévy et al. · Clinical Immunology · 2016 · 115 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines

Fernanda Tavares Da Silva, Filip De Keyser, Paul‐Henri Lambert et al. · Vaccine · 2013 · 80 citations · Full text

Veterinary Medicine, Immunology, Autoimmunity +16

Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans

Wivine Burny, Arnaud Marchant, Caroline Hervé et al. · Vaccine · 2019 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–5 of 14